Clinical trial

Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young…

NCT00275106 · Children's Cancer and Leukaemia Group, Other · Terminated

Key facts

NCT number NCT00275106
Title Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma
Official title Treatment Protocol for T-Cell and B-Precursor Cell Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL)
Lead sponsor Children's Cancer and Leukaemia Group, Other
Collaborators European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Lymphoma
Intervention type Drug, Procedure
Interventions asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, leucovorin calcium, mercaptopurine, methotrexate, prednisolone and 3 more
Enrollment 600
Start date Sep 1, 2004
Primary completion Dec 1, 2009
Completion Aug 1, 2012
First posted Jan 11, 2006
Last update posted Jul 10, 2013
Countries Germany, Ireland, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies